Featured Research

from universities, journals, and other organizations

Magnolia Compound Hits Elusive Target In Cancer Cells

Date:
July 14, 2008
Source:
Emory University
Summary:
The natural compound honokiol blocks survival signals from the Ras family of genes in breast, lung and bladder cancer cells. As a drug target, Ras is considered difficult to approach chemically. Honokiol comes from magnolia trees and has been used in Japanese and Chinese herbal medicines.

A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered "undruggable," researchers have found.

Related Articles


A laboratory led by Jack Arbiser, MD, PhD, at Emory University School of Medicine, has been studying the compound honokiol, found in Japanese and Chinese herbal medicines, since discovering its ability to inhibit tumor growth in mice in 2003.

"Knowing more about how honokiol works will tell us what kinds of cancer to go after," says Arbiser, who is an associate professor of dermatology. "We found that it is particularly potent against tumors with activated Ras."

Ras refers to a family of genes whose mutation stimulates the growth of several types of cancers. Although the Ras family is mutated in around a third of human cancers, medicinal chemists have considered it an intractable target.

Honokiol's properties could make it useful in combination with other antitumor drugs, because blocking Ras activation would prevent tumors from escaping the effects of these drugs, Arbiser says.

"Honokiol could be effective as a way to make tumors more sensitive to traditional chemotherapy," he says.

One of the effects of Ras is to drive pumps that remove chemotherapy drugs from cancer cells. In breast cancer cell lines with activations in Ras family genes, honokiol appears to prevent Ras from turning on an enzyme called phospholipase D, Arbiser and his colleagues found. It also has similar effects in lung and bladder cancer cells in the laboratory. Phospholipase D provides what have come to be known as "survival signals" in cancer cells, allowing them to stay alive when ordinary cells would die.

Arbiser's team's results were published in Clinical Cancer Research. The research was a collaboration with the laboratory of David Foster, PhD, at Hunter College of the City University of New York. Hunter graduate students Avalon Garcia and Yang Zheng are the first authors of the paper. The collaboration also involved the lab of Dafna Bar-Sagi at New York University School of Medicine.

Emory University is in the process of licensing honokiol and related compounds so that they can be tested in people in cooperation with industry partners.

The research was funded by the National Institutes of Health.

Dr. Arbiser, as an inventor of the technology, has a financial interest that has been reviewed and approved by Emory University in compliance with its conflict of interest policies.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Avalon Garcia, Yang Zheng, Chen Zhao, Alfredo Toschi, Judy Fan, Natalie Shraibman, H. Alex Brown, Dafna Bar-Sagi, David A. Foster and Jack L. Arbiser. Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells. Clinical Cancer Research, 4, 4267-4274, July 1, 2008 DOI: 10.1158/1078-0432.CCR-08-0102

Cite This Page:

Emory University. "Magnolia Compound Hits Elusive Target In Cancer Cells." ScienceDaily. ScienceDaily, 14 July 2008. <www.sciencedaily.com/releases/2008/07/080711214125.htm>.
Emory University. (2008, July 14). Magnolia Compound Hits Elusive Target In Cancer Cells. ScienceDaily. Retrieved November 25, 2014 from www.sciencedaily.com/releases/2008/07/080711214125.htm
Emory University. "Magnolia Compound Hits Elusive Target In Cancer Cells." ScienceDaily. www.sciencedaily.com/releases/2008/07/080711214125.htm (accessed November 25, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, November 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins